Enlarged Prostate (BPH): Symptoms and What Works

TL;DR: An enlarged prostate, known medically as benign prostatic hyperplasia or BPH, is a non-cancerous overgrowth of the prostate that is a near-universal part of getting older; about half of men in their fifties and the large majority in their eighties have it. The two most useful things to know come first. It is not prostate cancer, does not become cancer, and does not raise your cancer risk, because BPH grows in the inner zone of the prostate around the urethra while most cancer starts in the outer zone; they simply both become common with age, and their symptoms can overlap, which is why an evaluation still matters. And the size of the prostate correlates only loosely with how much trouble it causes, so a big gland can be silent and a modest one can be miserable. The symptoms are urinary: a weak stream, hesitancy, straining, a sense of incomplete emptying, frequency, urgency, and, most disruptive for many men, waking through the night to urinate. Treatment is matched to how much it bothers you, starting with lifestyle for mild symptoms, moving to medications that relax the prostate muscle or shrink the gland, and, when needed, to a growing menu of minimally invasive procedures, many of which now preserve ejaculation. In high-quality trials, saw palmetto works no better than a placebo, so it is not a reliable fix. A few red flags, above all a sudden inability to urinate at all, are medical emergencies.

What is an enlarged prostate, and how common is it?

The prostate is a walnut-sized gland that sits below the bladder and wraps around the urethra, the tube urine flows through. With age, the tissue in its inner zone tends to overgrow, a benign process that can squeeze the urethra and get in the way of the urine stream. That is benign prostatic hyperplasia, and it is one of the most common conditions of male aging. Looking at prostate tissue under a microscope, the changes of BPH appear in roughly 8 percent of men in their thirties, about half of men in their fifties, and 80 to 90 percent of men in their eighties.¹

A point that saves a lot of worry is that having an enlarged prostate on an exam or a scan is not the same as having a problem. Many men with a microscopically enlarged gland have no symptoms at all, and the size of the prostate lines up only loosely with how much trouble it causes, so a large gland can be quiet while a modestly enlarged one blocks the flow and disrupts sleep. What matters is not the measurement but the symptoms and how much they bother you, which is the thread that runs through the rest of this article.

Is an enlarged prostate the same as prostate cancer?

No, and this is the reassurance most men are looking for, with one important footnote. Benign prostatic hyperplasia and prostate cancer are different diseases that happen to share an organ. BPH grows in the transition zone, the inner tissue hugging the urethra, which is why it obstructs the stream. Most prostate cancer arises in the peripheral zone, the outer rim of the gland, which is why early cancer often causes no urinary symptoms at all. An enlarged prostate does not turn into cancer, does not cause cancer, and does not raise your risk of it.

The footnote is that both conditions become more common with age, so they often coexist in the same man simply by coincidence of getting older, and their symptoms can overlap. That is why an enlarged prostate still deserves a proper look rather than a shrug: not because BPH is dangerous, but because the evaluation is also the moment to think about whether prostate cancer screening makes sense for you. The reassurance and the evaluation go together. You can stop fearing that your enlarged prostate is a cancer in the making, and still use the visit to make a sound, shared decision about screening.

What are the symptoms, and how bad is bad?

The symptoms of an enlarged prostate are all about urination, and they fall into two groups. The voiding symptoms come from the blocked stream: a weak or slow flow, difficulty getting started, straining, a stream that stops and starts, dribbling at the end, and a feeling that the bladder never fully empties. The storage symptoms come from the bladder reacting to the obstruction over time: needing to go often, a sudden urgency that is hard to defer, and waking at night to urinate. For many men that last one, nocturia, is the most disruptive of all, because broken sleep drags on energy, mood, and, in older men, raises the risk of a nighttime fall.

To put a number on severity, urologists use a short questionnaire called the International Prostate Symptom Score, or IPSS, which rates seven symptoms and sorts men into mild, moderate, and severe categories, alongside a separate question about how much the symptoms bother their quality of life.² That last question carries a lot of weight, because the decision to treat is driven less by the raw score than by how much the symptoms interfere with your life. Two men with the same score can make very different, and equally reasonable, choices depending on how much the nightly trips or the weak stream wear on them.

How is an enlarged prostate evaluated, and what about PSA?

The workup is simple and mostly about sorting benign symptoms from anything that needs more attention. It starts with your history and symptom score, a digital rectal exam to feel the prostate, and a urine test to rule out an infection or blood, which can mimic or complicate the picture. From there the path depends on what is found and how bothered you are.

The PSA blood test deserves its own note, because it causes a lot of confusion in this setting. An enlarged prostate makes more PSA simply by having more tissue, so a mildly high PSA is common in men with BPH and does not by itself mean cancer. That does not make PSA useless, since it also gives a rough sense of prostate size and future progression risk, but it does mean the number has to be read in context, and whether to check it at all is a shared decision rather than an automatic step. What should prompt a referral to a urologist is a set of complicating features: an inability to urinate, visible blood in the urine, repeated urinary infections, bladder stones, signs of strain on the kidneys, or symptoms that do not respond to first treatments.

What works? The treatment ladder

Treatment climbs a ladder, and where you start depends on how much the symptoms bother you, guided by the current urology guideline.⁸ For mild or tolerable symptoms, watchful waiting with lifestyle changes is a sound first step: cutting back on fluids in the evening, easing off caffeine and alcohol, which irritate the bladder, emptying the bladder twice in a row, and reviewing medications, since common decongestants can tighten the bladder neck and tip a man into trouble.

When symptoms warrant medication, there are two main classes that work differently. Alpha-blockers, such as tamsulosin, relax the muscle of the prostate and bladder neck and improve the stream within days, but they do not shrink the gland; their trade-offs are lightheadedness, changes in ejaculation, and a floppy-iris effect that your eye surgeon must know about before cataract surgery. The 5-alpha-reductase inhibitors, finasteride and dutasteride, do shrink the prostate over months and are the only medicines shown to lower the risk of urinary retention and future surgery, which makes them most useful for larger glands.³⁴ They carry two caveats worth stating plainly: they cut the PSA level by about half, so the number has to be doubled when read for cancer screening, and they can affect libido and sexual function. Combining the two classes beats either alone for men with larger prostates and higher progression risk. A third option, a daily low dose of the erectile-dysfunction drug tadalafil, is approved for urinary symptoms and is appealing when a man has both problems at once.

When medication is not enough, or not tolerated, a range of procedures can open the channel, and the modern menu is far kinder to sexual function than the old operations. Several minimally invasive options, including a device that lifts the prostate lobes aside, steam therapy, and a temporary implant, relieve obstruction while preserving ejaculation, and a robotic water-jet method and a newer drug-coated balloon extend those choices further. The long-standing surgical standard, a transurethral resection, is highly effective but usually causes ejaculation to go backward into the bladder. The point is that no man has to simply live with severe symptoms; there is a wide and improving set of tools, and the right one depends on the size of the gland, your priorities, above all whether preserving ejaculation matters to you, and your surgeon's judgment.

Does saw palmetto work?

This is the myth worth dispelling, because saw palmetto is the most heavily marketed prostate supplement, and the best evidence shows it works no better than a placebo. In a rigorous trial, men taking saw palmetto for a year improved no more than men taking a placebo.⁶ A later, even more demanding trial pushed the dose up to three times the usual amount over eighteen months and still found no benefit over placebo; if anything the placebo edged it out.⁷ A pooled analysis of the trials reached the same verdict. The other popular prostate supplements, beta-sitosterol, pygeum, pumpkin seed, stinging nettle, and the various DHT-blocker blends, rest on weaker and lower-quality evidence, and none has been shown to shrink the prostate.

The honest takeaway is that the strongest evidence does not support saw palmetto or the other prostate supplements for treating an enlarged prostate. This is not a knock on trying to help yourself; it is a redirection. The effort spent on saw palmetto tends to pay off more when aimed at the lifestyle steps above, a proven medication if symptoms warrant it, or a conversation with a clinician about whether a procedure fits. Being skeptical of the supplement aisle here is not cynicism, it is following the trials where they lead.

When is it an emergency, and does lifestyle help?

Most of an enlarged prostate is a quality-of-life problem, but a few situations are urgent and should not wait. A sudden, complete inability to urinate with a painful, full bladder, called acute urinary retention, is a medical emergency that needs prompt catheterization. Visible blood in the urine, repeated urinary infections, bladder stones, and any sign that the back-pressure is straining the kidneys all call for prompt urologic evaluation rather than watchful waiting. These are the moments where the calm, take-your-time framing of the rest of this article does not apply.

On the gentler end, there is a fair question about whether lifestyle and metabolic health move the needle. The observational evidence is suggestive: men with metabolic syndrome, obesity, diabetes, and low activity tend to have larger prostates and worse urinary symptoms, while more physically active men tend to have milder symptoms. The honest limit is that these are associations, and no trial has shown that losing weight or exercising shrinks the prostate or reverses BPH. So the fair way to hold it is that pursuing metabolic health and staying active are worth doing on their own considerable merits, and they travel with milder urinary symptoms, without overpromising them as a cure for the prostate itself.

Guidance from the Clinic

"The two things I most want a man with urinary symptoms to hear are that an enlarged prostate is not cancer and does not become cancer, and that he does not have to just live with the symptoms. Most men arrive privately worried it is cancer, and once I explain that BPH grows in a different part of the gland, the relief is visible, though I still use the visit to make a thoughtful decision with him about PSA and screening. Then we match the treatment to how much it bothers him. If it is mild, we adjust fluids and medications and watch. If it is bothersome, we have good drugs, and I am careful to remind men on finasteride to double their PSA when we read it. If it is severe, the newer procedures can open things up while protecting ejaculation, which matters to a lot of men and is worth asking about. The one place I steer men gently is saw palmetto: the strongest trials show it works no better than placebo, and I would rather a man spend that effort on something proven. Nobody has to choose between fearing cancer and suffering in silence. There is a calmer, evidence-based path between them."

Related at Fishtown Medicine

• PSA and Prostate Cancer Screening: Should You Get It? - how to read a PSA, including the doubling rule on finasteride, and the cancer-screening decision
• Saw Palmetto: A Clinical Guide - a fuller look at the most-marketed prostate supplement
• Beta-Sitosterol: A Clinical Guide - the phytosterol marketed for the prostate, and its weaker evidence
• Erectile Dysfunction and Vascular Health - the overlapping men's-health issue, and where tadalafil treats both
• Men's Hormone Health - testosterone, andropause, and the fuller picture of aging in men

Scientific References

1. Berry SJ, Coffey DS, Walsh PC, Ewing LL. "The Development of Human Benign Prostatic Hyperplasia with Age." Journal of Urology. 1984;132(3):474-479.
2. Barry MJ, Fowler FJ, O'Leary MP, et al. "The American Urological Association Symptom Index for Benign Prostatic Hyperplasia." Journal of Urology. 1992;148(5):1549-1557.
3. McConnell JD, Roehrborn CG, Bautista OM, et al. "The Long-Term Effect of Doxazosin, Finasteride, and Combination Therapy on the Clinical Progression of Benign Prostatic Hyperplasia (MTOPS)." New England Journal of Medicine. 2003;349(25):2387-2398.
4. Roehrborn CG, Siami P, Barkin J, et al. "The Effects of Combination Therapy with Dutasteride and Tamsulosin on Clinical Outcomes in Men with Symptomatic Benign Prostatic Hyperplasia: 4-Year Results from the CombAT Study." European Urology. 2010;57(1):123-131.
5. Thompson IM, Goodman PJ, Tangen CM, et al. "The Influence of Finasteride on the Development of Prostate Cancer (Prostate Cancer Prevention Trial)." New England Journal of Medicine. 2003;349(3):215-224.
6. Bent S, Kane C, Shinohara K, et al. "Saw Palmetto for Benign Prostatic Hyperplasia." New England Journal of Medicine. 2006;354(6):557-566.
7. Barry MJ, Meleth S, Lee JY, et al. "Effect of Increasing Doses of Saw Palmetto Extract on Lower Urinary Tract Symptoms: A Randomized Trial (CAMUS)." JAMA. 2011;306(12):1344-1351.
8. American Urological Association. "Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline (2026)." Journal of Urology. 2026. (Part I doi:10.1097/JU.0000000000005097; Part II, Medical Management, doi:10.1097/JU.0000000000005098.)
9. Andriole GL, Bostwick DG, Brawley OW, et al. "Effect of Dutasteride on the Risk of Prostate Cancer (REDUCE)." New England Journal of Medicine. 2010;362(13):1192-1202.